mhurhangee/ep-ind-claims huggingface dataset:
A method for limiting the throughput of a communication in a meshed network, comprising the following steps: • allocating respective static paths to potential communications between source nodes and destination nodes of the network, such that at least one mesh segment (N12-N13) between adjacent network nodes is crossed by multiple static paths; • statically allocating respective throughput quotas (8, 4, 4) to the communications, such that, in any mesh segment, the sum of the quotas allocated to the communications that can take the mesh segment is at most equal to a nominal throughput of the mesh segment; • transmitting data units of a current communication; • measuring the throughput of the current communication at the source node of the communication; and • temporarily suspending the current communication at the source node when its quota is reached. • allocating respective static paths to potential communications between source nodes and destination nodes of the network, such that at least one mesh segment (N12-N13) between adjacent network nodes is crossed by multiple static paths; • statically allocating respective throughput quotas (8, 4, 4) to the communications, such that, in any mesh segment, the sum of the quotas allocated to the communications that can take the mesh segment is at most equal to a nominal throughput of the mesh segment; • transmitting data units of a current communication; • measuring the throughput of the current communication at the source node of the communication; and • temporarily suspending the current communication at the source node when its quota is reached.
An apparatus comprising: a Physical layer, PHY, block (910, 1000) comprising a plurality of PHY Physical Interface for PCI Express, PIPE, registers; a Media Access Control layer, MAC, block (905, 1100) comprising a plurality of MAC PIPE registers; and a PHY/MAC interface configured to interface the PHY block (910, 1000) and the MAC block (905, 1100), the PHY/MAC interface comprising: a first set of wires configured to transfer a plurality of register commands between the PHY block (910, 1000) and the MAC block (905, 1100), at least some of the plurality of register commands comprising command, address and data to be transferred via the first set of wires over a plurality of clock cycles; and a second set of wires configured to transfer datapath signals between the PHY block (910, 1000) and the MAC block (905, 1100), characterized in that the PHY block (910, 1000) further comprises a clocking multiplexer, MUX,, the clocking MUX having a first input as the PCLK from the MAC block (905, 1100) and has a second input as the recovered clock from received data, in a first mode, the PHY block (910, 1000) is configured to send data, and a PCLK from an output of the clocking MUX, to the MAC block; and in a second mode, the PHY block is configured to send data, and a recovered clock from the output of the clocking MUX, to to the MAC block, a Physical layer, PHY, block (910, 1000) comprising a plurality of PHY Physical Interface for PCI Express, PIPE, registers; a Media Access Control layer, MAC, block (905, 1100) comprising a plurality of MAC PIPE registers; and a PHY/MAC interface configured to interface the PHY block (910, 1000) and the MAC block (905, 1100), the PHY/MAC interface comprising: a first set of wires configured to transfer a plurality of register commands between the PHY block (910, 1000) and the MAC block (905, 1100), at least some of the plurality of register commands comprising command, address and data to be transferred via the first set of wires over a plurality of clock cycles; and a second set of wires configured to transfer datapath signals between the PHY block (910, 1000) and the MAC block (905, 1100), a first set of wires configured to transfer a plurality of register commands between the PHY block (910, 1000) and the MAC block (905, 1100), at least some of the plurality of register commands comprising command, address and data to be transferred via the first set of wires over a plurality of clock cycles; and a second set of wires configured to transfer datapath signals between the PHY block (910, 1000) and the MAC block (905, 1100), characterized in that the PHY block (910, 1000) further comprises a clocking multiplexer, MUX,, the clocking MUX having a first input as the PCLK from the MAC block (905, 1100) and has a second input as the recovered clock from received data, in a first mode, the PHY block (910, 1000) is configured to send data, and a PCLK from an output of the clocking MUX, to the MAC block; and in a second mode, the PHY block is configured to send data, and a recovered clock from the output of the clocking MUX, to to the MAC block,
Method for automated examination of biological material with a microscope, on the cross table of which said biological material is arranged between an object slide or an analysis plate and at least one cover, wherein said biological material is exposed to light, wherein with an image recording unit at least one image of said biological material enlarged by means of the object lens of said microscope is recorded and transferred to an evaluation unit, and wherein using a device for automatic focusing of said biological material labeling is detected, a position and/or location of said labeling is determined and, based on said detected position and/or location of said labeling, focusing of said biological material is undertaken by targeted movement of said cross table, characterized in that said biological material is provided on a biochip manufactured by fragmentation and division of a cover slip, on which biochip said biological material is arranged, and said labeling is detected on a surface of said biochip, - wherein a target interval can be determined on the basis of determination of a location and/or a position of said labeling, - wherein said target interval comprises a maximum and minimum distance to the object lens - and wherein focusing of said biological material on the biochip takes place by images being taken at two different levels within said target range and said images being evaluated. - wherein a target interval can be determined on the basis of determination of a location and/or a position of said labeling, - wherein said target interval comprises a maximum and minimum distance to the object lens - and wherein focusing of said biological material on the biochip takes place by images being taken at two different levels within said target range and said images being evaluated.
Component of a water feature for generating an illuminated water pattern, in particular for horizontal installation, comprising a lighting unit fixedly arranged in a housing and a water channel passing through the housing, in particular centrally, which channel has a round cross-section at least in regions, characterized in that the component has, in at least one longitudinal portion of the water channel, at least one projection protruding toward a central longitudinal axis of the water channel as part of a nozzle receptacle, such that the water channel, in the longitudinal portion in which the projection is located, does not have a round cross-section, at least in regions.
A compound of Formula (Ia): wherein: R 1 is hydrogen, optionally substituted C 1-6 alkyl, -CH 2 OH, -CH 2 OP (OR 20)(OR 21), -C R 22, or -SO 2 R 23; R 2 is hydrogen, optionally substituted C 1-6 alkyl, cycloalkyl, or halo; each of R 3, R 4, R 5, R 6, R 9, R 10, R 11, R 12 and R 13 is independently hydrogen, hydroxyl, -OP (OR 20)(OR 21), -CH 2 OH, -CH 2 OP (OR 20)(OR 21), optionally substituted alkyl, optionally substituted alkylene, optionally substituted alkynyl, optionally substituted alkoxy, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted heteroaralkyl, optionally substituted heterocyclyl, aminocarbonyl, acyl, acylamino, -O-(C 1 to C 6 -alkyl)-O-(C 1 to C 6 -alkyl), cyano, halo, - SO 2 NR 24 R 25; or -NR 24 R 25; R 7 is hydrogen or optionally substituted C 1-6 alkyl; each of R 20 and R 21 is independently Na +, Li +, K +, hydrogen, C 1-6 alkyl; or R 20 and R 21 can be combined to represent a single divalent cation Zn 2+, Ca 2+, or Mg 2+. each of R 22 and R 23 is independently optionally substituted alkyl, optionally substituted alkoxy, optionally substituted cycloalkyl, optionally substituted aryl, or -NR 24 R 25; and each of R 24 and R 25 is independently chosen from hydrogen or C 1-6 alkyl or when combined together with the nitrogen to which they are attached form a heterocycle; or a pharmaceutically acceptable salt, ester, single stereoisomer, mixture of stereoisomers, or tautomer thereof. R 1 is hydrogen, optionally substituted C 1-6 alkyl, -CH 2 OH, -CH 2 OP (OR 20)(OR 21), -C R 22, or -SO 2 R 23; R 2 is hydrogen, optionally substituted C 1-6 alkyl, cycloalkyl, or halo; each of R 3, R 4, R 5, R 6, R 9, R 10, R 11, R 12 and R 13 is independently hydrogen, hydroxyl, -OP (OR 20)(OR 21), -CH 2 OH, -CH 2 OP (OR 20)(OR 21), optionally substituted alkyl, optionally substituted alkylene, optionally substituted alkynyl, optionally substituted alkoxy, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted heteroaralkyl, optionally substituted heterocyclyl, aminocarbonyl, acyl, acylamino, -O-(C 1 to C 6 -alkyl)-O-(C 1 to C 6 -alkyl), cyano, halo, - SO 2 NR 24 R 25; or -NR 24 R 25; R 7 is hydrogen or optionally substituted C 1-6 alkyl; each of R 20 and R 21 is independently Na +, Li +, K +, hydrogen, C 1-6 alkyl; or R 20 and R 21 can be combined to represent a single divalent cation Zn 2+, Ca 2+, or Mg 2+. each of R 22 and R 23 is independently optionally substituted alkyl, optionally substituted alkoxy, optionally substituted cycloalkyl, optionally substituted aryl, or -NR 24 R 25; and each of R 24 and R 25 is independently chosen from hydrogen or C 1-6 alkyl or when combined together with the nitrogen to which they are attached form a heterocycle; or a pharmaceutically acceptable salt, ester, single stereoisomer, mixture of stereoisomers, or tautomer thereof.
A power supply circuit that supplies control supply voltage for giving a control signal to a switching element (71, 72), the power supply circuit comprising: a switching power supply including a first output circuit (1b, 1c) for supplying a control supply voltage to a control terminal of the switching element, and a second output circuit the switching power supply uses the output voltage of the second output circuit for feedback control for keeping the output voltage of the second output circuit within a predetermined range, and thereby keeping the output voltage of the first output circuit (1b, 1c) within an allowable range; and a monitoring circuit that monitors the output voltage of the second output circuit, characterized in that: there is provided a regulator circuit that reduces the output voltage of the second output circuit to a predetermined constant voltage and outputs the constant voltage, and the monitoring circuit is configured such that a subject voltage (Vin) obtained from the output voltage of the second output circuit is higher than a reference voltage (Vr) obtained from the constant voltage when the control supply voltage is normal, and the monitoring circuit outputs a signal to a control apparatus for stopping output of the control signal to the switching element (71, 72) when the subject voltage (Vin) becomes lower than the reference voltage (Vr) so that the switching elements (71,72) are switched OFF. a switching power supply including a first output circuit (1b, 1c) for supplying a control supply voltage to a control terminal of the switching element, and a second output circuit the switching power supply uses the output voltage of the second output circuit for feedback control for keeping the output voltage of the second output circuit within a predetermined range, and thereby keeping the output voltage of the first output circuit (1b, 1c) within an allowable range; and a monitoring circuit that monitors the output voltage of the second output circuit, there is provided a regulator circuit that reduces the output voltage of the second output circuit to a predetermined constant voltage and outputs the constant voltage, and the monitoring circuit is configured such that a subject voltage (Vin) obtained from the output voltage of the second output circuit is higher than a reference voltage (Vr) obtained from the constant voltage when the control supply voltage is normal, and the monitoring circuit outputs a signal to a control apparatus for stopping output of the control signal to the switching element (71, 72) when the subject voltage (Vin) becomes lower than the reference voltage (Vr) so that the switching elements (71,72) are switched OFF.
A cover system having a cover, which comprises the following: a foam body, which defines the contour of the cover with front side and a rear side, wherein the cover consists only of the foam body, wherein the foam body is formed from an integral foam, the density of which decreases from the outer side of the foam body in the direction of its interior, wherein the foam body has a cellular core and an outer skin, that becomes more dense toward its edge, on a front side and on a rear side thereof; and a fastening element, wherein a recess is formed into the rear side of the foam body, wherein the recess has a cavity that is closed towards the front side for receiving the fastening element, and is configured such that the fastening element in the recess comes in direct contact with the surface of the foam body, wherein the fastening element is able to be brought into engagement with the recess, wherein the fastening element has a head which is able to be brought into engagement with the recess, wherein the head has a diameter which is greater than a diameter of the recess. a foam body, which defines the contour of the cover with front side and a rear side, wherein the cover consists only of the foam body, wherein the foam body is formed from an integral foam, the density of which decreases from the outer side of the foam body in the direction of its interior, wherein the foam body has a cellular core and an outer skin, that becomes more dense toward its edge, on a front side and on a rear side thereof; and a fastening element, wherein a recess is formed into the rear side of the foam body, wherein the recess has a cavity that is closed towards the front side for receiving the fastening element, and is configured such that the fastening element in the recess comes in direct contact with the surface of the foam body, wherein the fastening element is able to be brought into engagement with the recess, wherein the fastening element has a head which is able to be brought into engagement with the recess, wherein the head has a diameter which is greater than a diameter of the recess.
A method of communicating in a cellular network, the method comprising receiving a candidate carrier from a first base station at a mobile device; characterized in that the method further comprises: determining at the mobile device a first reverse link transmit power level associated with the candidate carrier based on a pilot power level of the received candidate carrier; determining at the mobile device a difference between the first reverse link transmit power level and a second reverse link transmit power level corresponding to a second carrier used by the mobile device to communicate with a second base station; and updating at the mobile device a set of carriers available to the mobile device for communicating on the cellular network based on the difference between the first reverse link transmit power level and the second reverse link transmit power level. determining at the mobile device a first reverse link transmit power level associated with the candidate carrier based on a pilot power level of the received candidate carrier; determining at the mobile device a difference between the first reverse link transmit power level and a second reverse link transmit power level corresponding to a second carrier used by the mobile device to communicate with a second base station; and updating at the mobile device a set of carriers available to the mobile device for communicating on the cellular network based on the difference between the first reverse link transmit power level and the second reverse link transmit power level.
A fusion protein which simultaneously regulates plasma glucose and lipid and possesses a prolonged plasma half-life, wherein the peptide chain is conjugated from N- to C-terminal as follows: R1-R2, R2-R1, R1-L-R2 or R2-L-R1; wherein R1 is human fibroblast growth factor 21; R2 is Exendin-4; and L is a linker.
Fitting for water pipes, having at least one connecting stub, onto which can be pushed a pipe end which is to be connected, having an outer part, which encloses the connecting stub and, with an outer side of the connecting stub, forms an interspace, into which can be pushed the pipe end which is to be connected, having a control ring, which is arranged in the interspace, and, when the pipe end is being pushed in, is displaced by said pipe end, in the interspace, from a first position into a second position, and having at least one sealing ring, which is mounted in a groove of the connecting stub and, when the pipe end has been pushed in, seals said pipe end in relation to the connecting stub, wherein the control ring, in the first position, is arranged in such a way that, during installation, it is pushed, by the pipe end which is to be connected, over the at least one sealing ring, in order thus to prevent the latter from rolling out, and wherein the aforementioned interspace has arranged in it a restraining means, by way of which the pipe end once installed, can be fixed axially, characterized in that the control ring, in the aforementioned first position, is positioned on said restraining means, wherein the control ring is retained in a releasable manner on the restraining means, and wherein the control ring is retained on the restraining means by means of a latching connection or by a friction fit.
A method, comprising: receiving a pilot signal over a first channel at a receiver; receiving a rate indicator signal over a second channel at the receiver; characterized by: determining a rate indicator signal-to-noise ratio of the rate indicator signal based on a plurality of rate indicator channel symbols that are accumulated at the receiver; and estimating a pilot SNR of the pilot signal based on the rate indicator SNR of the rate indicator signal and a rate indicator channel-to-pilot ratio; wherein the rate indicator signal indicates a data rate at which a data signal is received over a third channel. receiving a pilot signal over a first channel at a receiver; receiving a rate indicator signal over a second channel at the receiver; characterized by: determining a rate indicator signal-to-noise ratio of the rate indicator signal based on a plurality of rate indicator channel symbols that are accumulated at the receiver; and estimating a pilot SNR of the pilot signal based on the rate indicator SNR of the rate indicator signal and a rate indicator channel-to-pilot ratio; wherein the rate indicator signal indicates a data rate at which a data signal is received over a third channel. determining a rate indicator signal-to-noise ratio of the rate indicator signal based on a plurality of rate indicator channel symbols that are accumulated at the receiver; and estimating a pilot SNR of the pilot signal based on the rate indicator SNR of the rate indicator signal and a rate indicator channel-to-pilot ratio; wherein the rate indicator signal indicates a data rate at which a data signal is received over a third channel.
A pharmaceutical composition comprising one or more antisense oligonucleotides in a pharmaceutically acceptable diluent, solvent, carrier, salt and/or adjuvant for use in treating or preventing Angelman syndrome in a subject, wherein the one or more antisense oligonucleotide comprises a nucleotide sequence of 10 to 30 nucleotides in length with 100% complementarity to a contiguous portion of nucleic acid sequence selected from SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, and SEQ ID NO:5, wherein the antisense oligonucleotide is capable of targeting the 5' end of UBE3A-AS transcript.
A method of determining a user's training load characterizing a physical load experienced by the user in response to an exercise, comprising: computing protein expenditure during the exercise associated with the user in a first computer process, wherein the protein expenditure is computed from measured exercise intensity information and carbohydrate reserve information associated with the user during the exercise according to a determined protein combustion model characterizing the user's metabolic protein combustion process as a function of the user's personal characteristics, the carbohydrate reserves, and the_measured exercise intensity information, wherein the measured exercise intensity information is represented by at least one of measured heart rate information, activity information, running speed information, and cycling speed information, and wherein the carbohydrate reserve information during the exercise is determined using a carbohydrate combustion rate determined on the basis of the exercise intensity information and further using carbohydrate reserve information representing the user's carbohydrate reserve at a beginning of at least one exercise session; and determining the user's training load based on the computed protein combustion information in a second computer process. computing protein expenditure during the exercise associated with the user in a first computer process, wherein the protein expenditure is computed from measured exercise intensity information and carbohydrate reserve information associated with the user during the exercise according to a determined protein combustion model characterizing the user's metabolic protein combustion process as a function of the user's personal characteristics, the carbohydrate reserves, and the_measured exercise intensity information, wherein the measured exercise intensity information is represented by at least one of measured heart rate information, activity information, running speed information, and cycling speed information, and wherein the carbohydrate reserve information during the exercise is determined using a carbohydrate combustion rate determined on the basis of the exercise intensity information and further using carbohydrate reserve information representing the user's carbohydrate reserve at a beginning of at least one exercise session; and determining the user's training load based on the computed protein combustion information in a second computer process.
A mucoadhesive capsule comprising pullulan containing a capsule fill formulation comprising a selective progesterone receptor modulator (SPRM) and one or more excipients for transmucosal administration to the vaginal mucosa of a female for the treatment of a progesterone-dependent condition selected from the group consisting of endometriosis and pain associated therewith, adenomyosis, endometriomas of the ovary, dysmenorrhea, uterine fibroids, endometrial hyperproliferation, ovarian cancer, and cervical cancer.